Suciu S - Search Results

1

Statistical methodology of phase III cancer clinical trials: advances and future perspectives.

Sylvester R, Van Glabbeke M, Collette L, Suciu S, Baron B, Legrand C, Gorlia T, Collins G, Coens C, Declerck L, Therasse P. Sylvester R, et al. Among authors: suciu s. Eur J Cancer. 2002 Mar;38 Suppl 4:S162-8. doi: 10.1016/s0959-8049(01)00442-7. Eur J Cancer. 2002. PMID: 11858987

2

Comparability of prostate trials.

Suciu S, Sylvester R, Iversen P, Christensen I, Denis L. Suciu S, et al. Cancer. 1993 Dec 15;72(12 Suppl):3841-6. doi: 10.1002/1097-0142(19931215)72:12+<3841::aid-cncr2820721715>3.0.co;2-3. Cancer. 1993. PMID: 8252500 Review.

3

Comparability of EORTC and DAPROCA studies in advanced prostatic cancer.

Suciu S, Sylvester R, Iversen P, Christensen I, Denis L. Suciu S, et al. Cancer. 1990 Sep 1;66(5 Suppl):1029-34. doi: 10.1002/cncr.1990.66.s5.1029. Cancer. 1990. PMID: 2144205 Clinical Trial.

4

Time-dependent prognostic factors in advanced prostatic cancer.

Suciu S, Sylvester RJ, Yamanaka H. Suciu S, et al. Prog Clin Biol Res. 1990;357:203-15. Prog Clin Biol Res. 1990. PMID: 2217465 Review. No abstract available.

5

Prognostic factors for randomization and stratification and endpoints for the evaluation of trials.

Sylvester RJ, Suciu S, Yamanaka H. Sylvester RJ, et al. Among authors: suciu s. Prog Clin Biol Res. 1988;269:275-87. Prog Clin Biol Res. 1988. PMID: 3293065 Review. No abstract available.

6

Zoladex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer. A combined analysis of two European studies, EORTC 30853 and DAPROCA 86.

Iversen P, Suciu S, Sylvester R, Christensen I, Denis L. Iversen P, et al. Among authors: suciu s. Cancer. 1990 Sep 1;66(5 Suppl):1067-73. doi: 10.1002/cncr.1990.66.s5.1067. Cancer. 1990. PMID: 2144208 Clinical Trial.

7

Professor Maurice Staquet, MD, MS (1930 - 2013).

Duez N, Eeckhoudt D, Kirkpatrick A, Solbu G, Suciu S, Sylvester R, Van Glabbeke M, Buyse M, Dalesio O, Renard J, Rotmensz N. Duez N, et al. Among authors: suciu s. Stat Med. 2013 Dec 30;32(30):5219-20. doi: 10.1002/sim.6034. Epub 2013 Oct 31. Stat Med. 2013. PMID: 24302281 No abstract available.

8

Relation between estrogen receptor concentration and clinical and histological factors: their relative prognostic importance after radical mastectomy for primary breast cancer.

Andry G, Suciu S, Pratola D, Sylvester R, Leclercq G, da Costa PM, Legros N, Andry-t'Hooft M, Verhest A, Mattheiem W, et al. Andry G, et al. Among authors: suciu s. Eur J Cancer Clin Oncol. 1989 Feb;25(2):319-29. doi: 10.1016/0277-5379(89)90025-4. Eur J Cancer Clin Oncol. 1989. PMID: 2702986

9

Multivariate analysis of prognostic factors in patients with advanced prostatic cancer: results from 2 European Organization for Research on Treatment of Cancer trials.

de Voogt HJ, Suciu S, Sylvester R, Pavone-Macaluso M, Smith PH, de Pauw M. de Voogt HJ, et al. Among authors: suciu s. J Urol. 1989 Apr;141(4):883-8. doi: 10.1016/s0022-5347(17)41039-1. J Urol. 1989. PMID: 2522561 Clinical Trial.

10

The Children Leukemia Group: 30 years of research and achievements.

Otten J, Philippe N, Suciu S, Béhar C, Babin-Boilletot A, Thyss A, Ferster A, Vilmer E; EORTC Children Leukemia Group. Otten J, et al. Among authors: suciu s. Eur J Cancer. 2002 Mar;38 Suppl 4:S44-9. doi: 10.1016/s0959-8049(01)00449-x. Eur J Cancer. 2002. PMID: 11858964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

311 results

Search Page